Male infertility has long been viewed through the narrow lens of adulthood. Lifestyle, illness, age, and workplace hazards often dominate the conversation.

Yet a growing body of evidence is quietly shifting that focus much further back in time. New human research now suggests that chemical exposures during foetal development and childhood may leave lasting marks on male reproductive health, detectable decades later in the most fundamental unit of reproduction — sperm.

Roughly 7% of men worldwide are affected by infertility, a figure that carries profound personal, social, and economic consequences. While declining sperm counts and quality have been documented across many regions, the reasons behind these trends remain contested.

Animal studies have repeatedly shown that early-life exposure to certain industrial chemicals can disrupt reproductive development. Until recently, however, direct human evidence linking prenatal and childhood chemical exposure to specific genetic abnormalities in sperm has been scarce.

That gap is beginning to close. A newly published study in the peer‑reviewed journal Environmental Health offers some of the clearest human data yet. Conducted by a team of environmental health scientists and epidemiologists, the research suggests that exposure to persistent environmental chemicals before birth and during childhood is associated with abnormal numbers of chromosomes in sperm during adulthood.

The findings raise important questions about how invisible exposures early in life may shape reproductive health decades later.

At the centre of the study is a concept known as sperm aneuploidy. In simple terms, healthy human sperm contain 23 chromosomes, carrying the genetic material required to form an embryo. Any deviation from that number can disrupt normal development. Extra or missing chromosomes in sperm are associated with infertility, miscarriage, and congenital conditions. Among these is Klinefelter syndrome, a genetic disorder caused by the presence of an extra X chromosome, which can impair physical development and fertility.

“Higher levels of PCBs and PFAS in early life were associated with sperm containing extra chromosomes in adulthood”

The researchers analysed semen samples from men aged between 22 and 24. These individuals were not recruited randomly from the general population. Instead, they were part of a unique long‑term cohort that allowed scientists to look backwards in time. Their mothers had provided blood samples during pregnancy in the late 1980s, a period when many industrial chemicals were still widely used. The same individuals also had blood samples taken during childhood, at the ages of seven and fourteen. This rare archive of biological data made it possible to trace chemical exposure from the womb through adolescence and into early adulthood.

The chemicals of interest were so‑called “forever chemicals”. These include polychlorinated biphenyls, commonly known as PCBs, and perfluoroalkyl substances, often grouped under the term PFAS. Both families of chemicals are characterised by their extreme persistence in the environment and the human body. They do not easily break down. Once absorbed, they can remain for years, sometimes decades.

“Even when sperm counts fall within normal ranges, chromosomal abnormalities can reduce the likelihood of successful conception or increase the risk of adverse pregnancy outcomes”

PCBs were widely used in electrical equipment, building materials, and industrial processes throughout much of the twentieth century and almost everywhere. Although banned or heavily restricted in many countries, they continue to circulate in ecosystems, particularly in aquatic environments. PFAS, meanwhile, are still present in many everyday products, including non‑stick cookware, stain‑resistant fabrics, firefighting foams, and food packaging. Exposure can occur through food, drinking water, air, and consumer goods.

Using advanced laboratory techniques, the scientists measured levels of these chemicals in maternal blood samples taken during pregnancy. They then examined blood samples from the same offspring during childhood. Years later, semen samples provided by the now‑adult men were analysed for chromosomal abnormalities. The results revealed a consistent pattern. Higher levels of PCBs and PFAS in early life were associated with sperm containing extra chromosomes in adulthood.

The type of abnormality appeared to vary by chemical. PCB exposure was mainly linked to sperm carrying an extra Y chromosome. PFAS exposure showed a broader effect, associated with extra copies of both X and Y chromosomes. While the study did not assess fertility outcomes directly, these forms of sperm aneuploidy are widely recognised as markers of impaired reproductive potential.

Scientists emphasise that sperm quality is not just about quantity or movement. Genetic integrity matters. Even when sperm counts fall within normal ranges, chromosomal abnormalities can reduce the likelihood of successful conception or increase the risk of adverse pregnancy outcomes.

In this context, the presence of extra sex chromosomes in sperm represents a subtle but significant threat to reproductive health.

One of the most striking aspects of the research is its timing. The exposures occurred long before the men reached puberty, let alone considered starting families. This supports the idea that there are critical windows of vulnerability during development, periods when the reproductive system is especially sensitive to environmental insults. Damage sustained during these windows may not become apparent until many years later.

Experts involved in the research describe the findings as a warning signal. They suggest that chemical exposures during foetal life and early childhood can have enduring effects on the genetic quality of sperm. These effects may persist even if exposure levels decline later in life. The study adds weight to concerns that modern chemical environments may be contributing to observed declines in male reproductive health.

Diet and environment are likely sources of exposure. PCBs, despite being banned decades ago, remain present in fatty fish and other seafood, particularly from contaminated waters. Prenatal exposure may therefore occur through maternal diet. PFAS exposure is more diffuse. These chemicals are found in drinking water supplies, household dust, food packaging, and the air in some industrial or urban settings. Complete avoidance is difficult, if not impossible, under current conditions.

The research does not claim that chemical exposure is the sole cause of male infertility. Reproductive health is shaped by a complex interplay of genetics, lifestyle, medical history, and environment. Smoking, obesity, stress, infections, and heat exposure all play recognised roles. What this study does is highlight an upstream factor that has often been overlooked: the chemical environment experienced before birth.

Importantly, the scientists stress that their findings show association rather than direct causation. The study design cannot prove that PCBs or PFAS directly cause sperm aneuploidy. Other unmeasured factors could contribute. Nevertheless, the strength of the associations, combined with supporting evidence from animal research, makes the results difficult to dismiss.

Animal studies have long demonstrated that exposure to endocrine‑disrupting chemicals during development can interfere with hormone signalling, testicular formation, and sperm production. Many of these effects persist into adulthood. The current human study aligns with that evidence, suggesting that similar biological mechanisms may be at work in people.

“They suggest that chemical exposures during foetal life and early childhood can have enduring effects on the genetic quality of sperm. These effects may persist even if exposure levels decline later in life”

From a public health perspective, the implications are significant. Chemical exposure is not evenly distributed. Communities living near industrial sites, polluted waterways, or areas with contaminated drinking water often face higher levels of exposure. Socio‑economic factors can amplify these risks, raising concerns about environmental justice and intergenerational health inequality.

The findings also arrive at a time of growing regulatory scrutiny. Several countries are reconsidering safety thresholds for PFAS in drinking water and consumer products. Some have begun to phase out specific compounds, while others are considering broader class‑based bans. PCBs, though no longer produced, remain a costly legacy pollutant, requiring ongoing monitoring and remediation.

Public health researchers argue that prevention must sit at the heart of policy responses. Once these chemicals enter the environment, they are extremely difficult to remove. Reducing emissions, tightening regulations, and investing in safer alternatives may offer the most effective protection for future generations. From this perspective, reproductive health becomes not just a medical issue, but a policy one.

For individuals, the study may provoke concern, especially among those planning families. Experts caution against alarm. Many factors influence fertility, and the presence of chemical exposure does not guarantee reproductive problems. However, the research does reinforce the importance of broader efforts to reduce environmental contamination and improve chemical safety.

The study’s strength lies in its long‑term design, following participants from before birth into adulthood. Such studies are rare, expensive, and time‑consuming, yet they are uniquely valuable. They allow scientists to observe how early exposures translate into adult health outcomes, cutting through the noise of short‑term or cross‑sectional research.

There are also limitations. The sample size was relatively small, reflecting the challenges of maintaining long‑term cohorts. The participants were born in a specific time period, when chemical use patterns differed from today. Exposure levels may not be identical for children born now. Even so, many of these chemicals remain present, and some newer compounds share similar properties.

Future research will need to build on these findings. Larger studies, involving diverse populations, could help confirm the associations and explore dose‑response relationships. Investigations into underlying biological mechanisms may clarify how these chemicals disrupt chromosome separation during sperm development. Researchers are also interested in whether similar effects occur in female reproductive cells.

What is clear is that the story of male fertility begins earlier than previously assumed. The genetic health of sperm may be shaped long before adulthood, influenced by environments over which individuals have no control. This challenges traditional approaches to reproductive health, which often focus on adult behaviour while overlooking developmental origins.

As awareness grows, the hope among experts is that evidence like this will encourage more precautionary approaches to chemical management. Protecting reproductive health may require acting long before problems become visible. In the case of sperm aneuploidy linked to early‑life exposure, the damage may already be done by the time symptoms appear.

Male infertility is often silent, revealed only when conception fails. By then, the origins of the problem may lie decades in the past.

This new research invites a shift in perspective. It suggests that safeguarding fertility begins not in adulthood, but in the womb and the early years of life, shaped by the chemicals that surround us all.